GR3025318T3 - Substituted 1,2,3,4-tetrahydrocyclopent[b]indoles, 1,2,3,3a,4,8a-hexahydrocyclopent[b]indoles and related compounds, intermediates and a process for the preparation thereof and their use as medicaments - Google Patents

Substituted 1,2,3,4-tetrahydrocyclopent[b]indoles, 1,2,3,3a,4,8a-hexahydrocyclopent[b]indoles and related compounds, intermediates and a process for the preparation thereof and their use as medicaments

Info

Publication number
GR3025318T3
GR3025318T3 GR970402960T GR970402960T GR3025318T3 GR 3025318 T3 GR3025318 T3 GR 3025318T3 GR 970402960 T GR970402960 T GR 970402960T GR 970402960 T GR970402960 T GR 970402960T GR 3025318 T3 GR3025318 T3 GR 3025318T3
Authority
GR
Greece
Prior art keywords
indoles
intermediates
preparation
hexahydrocyclopent
tetrahydrocyclopent
Prior art date
Application number
GR970402960T
Other languages
Greek (el)
English (en)
Inventor
Helen Hu Ong
Gerard Joseph O'malley
Michael Clayton Merriman
Mark Gabriel Palermo
Original Assignee
Hoechst Marion Roussel Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Marion Roussel Inc filed Critical Hoechst Marion Roussel Inc
Publication of GR3025318T3 publication Critical patent/GR3025318T3/el

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56Ring systems containing three or more rings
    • C07D209/80[b, c]- or [b, d]-condensed
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Veterinary Medicine (AREA)
  • Neurology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Psychiatry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
GR970402960T 1991-01-18 1997-11-07 Substituted 1,2,3,4-tetrahydrocyclopent[b]indoles, 1,2,3,3a,4,8a-hexahydrocyclopent[b]indoles and related compounds, intermediates and a process for the preparation thereof and their use as medicaments GR3025318T3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/642,952 US5100891A (en) 1991-01-18 1991-01-18 Substituted 1,2,3,4-tetrahydrocyclopent[b]indoles, 1,2,3,3a,4,8a-hexahydrocyclopent[B]indoles and related compounds

Publications (1)

Publication Number Publication Date
GR3025318T3 true GR3025318T3 (en) 1998-02-27

Family

ID=24578739

Family Applications (1)

Application Number Title Priority Date Filing Date
GR970402960T GR3025318T3 (en) 1991-01-18 1997-11-07 Substituted 1,2,3,4-tetrahydrocyclopent[b]indoles, 1,2,3,3a,4,8a-hexahydrocyclopent[b]indoles and related compounds, intermediates and a process for the preparation thereof and their use as medicaments

Country Status (26)

Country Link
US (1) US5100891A (cs)
EP (1) EP0496314B1 (cs)
JP (1) JP2665422B2 (cs)
KR (1) KR100230881B1 (cs)
AT (1) ATE158790T1 (cs)
AU (1) AU650315B2 (cs)
BR (1) BR9200171A (cs)
CA (1) CA2059610C (cs)
CZ (1) CZ282732B6 (cs)
DE (1) DE69222444T2 (cs)
DK (1) DK0496314T3 (cs)
ES (1) ES2109953T3 (cs)
FI (2) FI102174B (cs)
GR (1) GR3025318T3 (cs)
HU (1) HUT67027A (cs)
IE (1) IE920149A1 (cs)
IL (1) IL100693A0 (cs)
MX (1) MX9200206A (cs)
NO (1) NO178397C (cs)
NZ (1) NZ241305A (cs)
PH (1) PH31429A (cs)
PL (2) PL169417B1 (cs)
RO (1) RO112505B1 (cs)
RU (1) RU2077530C1 (cs)
TW (1) TW198024B (cs)
ZA (1) ZA92341B (cs)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5298626A (en) * 1991-01-18 1994-03-29 Hoechst-Roussel Pharmaceuticals Incorporated Select cyclopent[b]indoles
US5350762A (en) * 1993-03-08 1994-09-27 Hoechst-Roussel Pharmaceuticals Incorporated Tetrahydrocyclopent[B]indole methanamines and related compounds
DE997458T1 (de) * 1997-07-03 2001-03-01 Asahi Kasei Kogyo K.K., Osaka Tricyclische verbindungen mit gesättigten ringen und diese enthaltende medizinische zubereitungen
TWI220143B (en) * 1998-05-13 2004-08-11 Solvay Pharm Gmbh Method for stereochemically controlled production of isomerically pure highly substituted azacyclic compounds and novel cyclic compounds, and intermediate products
AU759199B2 (en) * 1998-10-06 2003-04-10 Janssen Pharmaceutica N.V. Tricyclic delta3-piperidines as pharmaceuticals
UA69420C2 (uk) * 1998-10-06 2004-09-15 Янссен Фармацевтика Н.В. ТРИЦИКЛІЧНІ <font face="Symbol">D3</font>-ПІПЕРИДИНИ ЯК <font face="Symbol">a<sub></font>2</sub>-АНТАГОНІСТИ
UA70334C2 (en) * 1998-10-06 2004-10-15 Janssen Pharmaceutica N V Jans BENZOTHIENO[3,2-c]PYRIDINES AS a2 ANTAGONISTS BENZOTHIENO[3,2-c]PYRIDINES AS a2 ANTAGONISTS
IT1317926B1 (it) * 2000-11-03 2003-07-15 Sigma Tau Ind Farmaceuti Derivati triciclici dell'indolo ad attivita' antiangiogenica.
ATE411981T1 (de) 2003-06-10 2008-11-15 Smithkline Beecham Corp Tetrahydrocarbazolderivate und deren pharmazeutische verwendung
CA2528336A1 (en) 2003-06-12 2005-01-20 Smithkline Beecham Corporation Tetrahydrocarbazole derivatives and their pharmaceutical use
WO2006065480A2 (en) * 2004-11-23 2006-06-22 Ptc Therapeutics, Inc. Tetrahydrocarbazoles as active agents for inhibiting vegf production by translational control
GB2422828A (en) * 2005-02-03 2006-08-09 Hunter Fleming Ltd Tricyclic cytoprotective compounds comprising an indole residue
WO2013139929A1 (en) * 2012-03-22 2013-09-26 Ludwig-Maximilians-Universität München Novel means and methods for treating diseases of the central nervous system, metabolic and cardiac diseases and aging
KR20140013471A (ko) 2012-07-24 2014-02-05 주식회사 쎄코 진공증착용 발열조립체 및 이를 구비하는 진공증착장치
US10882821B1 (en) 2017-09-26 2021-01-05 The Board Of Trustees Of The Leland Stanford Junior University Enantiomeric compound for the reduction of the deleterious activity of extended nucleotide repeat containing genes

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3514462A (en) * 1966-10-21 1970-05-26 Upjohn Co 1 and 2 ethoxy 3,4,5,10 - tetrahydroazepino(3,4-b) and (2,3-b)indoles and corresponding amino derivatives thereof
US3595874A (en) * 1969-02-28 1971-07-27 Upjohn Co 3,4,5,10-tetrahydroazepino(2,3-b)indol-5a (2h)-ols
BE787537A (fr) * 1971-08-16 1973-02-14 Sterling Drug Inc Tetrahydrocarbazoles
SU482086A1 (ru) * 1973-11-30 1976-03-15 Всесоюзный Научно-Исследовательски% Химико-Фармацевтический Институт Им.С.Орджоникидзе Способ получени производных 1- -амино1,2,3,4-тетрагидрокарбазола
JPS5111760A (cs) * 1974-06-18 1976-01-30 Ayerst Mckenna & Harrison
US4254134A (en) * 1978-03-17 1981-03-03 Endo Laboratories, Inc. Antidepressant 2-amino- and -2-(substituted amino)-cis-hexahydro-carbazoles

Also Published As

Publication number Publication date
PL169417B1 (pl) 1996-07-31
RO112505B1 (ro) 1997-10-30
CA2059610C (en) 2002-04-02
PL293209A1 (en) 1993-04-05
EP0496314A1 (en) 1992-07-29
CZ282732B6 (cs) 1997-09-17
ZA92341B (en) 1992-09-30
FI102174B1 (fi) 1998-10-30
ATE158790T1 (de) 1997-10-15
IE920149A1 (en) 1992-07-29
MX9200206A (es) 1992-08-01
JP2665422B2 (ja) 1997-10-22
FI920192A0 (fi) 1992-01-16
NO920235L (no) 1992-07-20
EP0496314B1 (en) 1997-10-01
IL100693A0 (en) 1992-09-06
HU9200172D0 (en) 1992-04-28
PL296651A1 (en) 1993-07-26
TW198024B (cs) 1993-01-11
DE69222444T2 (de) 1998-06-04
CA2059610A1 (en) 1992-07-19
FI20001775L (fi) 2000-08-10
FI107919B (fi) 2001-10-31
NO178397C (no) 1996-03-20
DE69222444D1 (de) 1997-11-06
KR100230881B1 (ko) 1999-11-15
ES2109953T3 (es) 1998-02-01
AU1027992A (en) 1992-07-23
CS12992A3 (en) 1992-08-12
BR9200171A (pt) 1992-10-06
FI920192L (fi) 1992-07-19
JPH04334367A (ja) 1992-11-20
PH31429A (en) 1998-11-03
KR920014777A (ko) 1992-08-25
RU2077530C1 (ru) 1997-04-20
DK0496314T3 (da) 1998-05-18
PL167465B1 (pl) 1995-09-30
NO920235D0 (no) 1992-01-17
NO178397B (no) 1995-12-11
NZ241305A (en) 1994-10-26
FI102174B (fi) 1998-10-30
HUT67027A (en) 1995-01-30
US5100891A (en) 1992-03-31
AU650315B2 (en) 1994-06-16

Similar Documents

Publication Publication Date Title
GR3025318T3 (en) Substituted 1,2,3,4-tetrahydrocyclopent[b]indoles, 1,2,3,3a,4,8a-hexahydrocyclopent[b]indoles and related compounds, intermediates and a process for the preparation thereof and their use as medicaments
MY117274A (en) Polycyclic amine compounds and their enantiomers,their method of preparation and pharmaceutical compositions in which they are present.
MX9203346A (es) (+)-1-(3-dimetilaminopropil)-1-(4&#39;-fluorfenil)-1,3-dihidro-sobenofuran -5-carbonitrilo y sus sales de adicion de acido no toxicas farmaceuticamente utiles.
PT669920E (pt) 3-aminoalquilamino-1,2-benzoxazoles substituidos ecompostos relacionados
DE69216293D1 (de) 1,4-Disubstituierte Piperidinderivate, ihre Herstellung und therapeutische Verwendung
MY133445A (en) 2-arylethyl-(piperidin-4-ylmethyl)amine derivetives
UA26893C2 (uk) Спосіб отримаhhя оhдасетроhу та його фармацевтичhо прийhятhих солей
GR3018558T3 (en) [(Arylalkylpiperidine-4-yl)methyl]-2-alpha,3,4,5-tetrahydro-1(2H)-acenaphthylene-1-ones and related compounds, a process for their preparation and their use as medicaments
GR3024187T3 (en) Tetrahydrocyclopent[b]indole methanamines and related compounds, a process for their preparation and their use as medicaments.
DE69533214D1 (de) 2,3-Dihydro-1H-isoindolderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Hemmer der Serotoninwiederaufnahme
BR9707004A (pt) Composto processo para preparar o mesmo composição farmacêutica utilização do composto e processos para tratamento de doenças do sistema endocinológico e para a manufatura de um medicamento
DE69709252D1 (de) Coumarin-Derivate, Verfahren zu deren Herstellung und deren Verwendung
DK0758336T3 (da) Fremgangsmåde til fremstilling af 1-(3-trialkylsilylphenyl)-2,2,2-trifluorethanonderivater
TW429249B (en) Process for production a novel N-substituted pyrrolidine derivatives
MX9703368A (es) Procedimiento para la preparacion de derivados de 1-halogeno-3-trialquilsilanil-benceno.
ZA924888B (en) Process for the synthesis of enantiomers of 3-aminochroman compounds
ZA908309B (en) Dibenzodioxazecine and dibenzodioxaazacycloundecine derivatives